The sequencing service on gene mutations in cancer tissue of cancer patients was started in April 2015 with Kyoto University Hospital and later expanded to Okayama and Hokkaido University Hospital. By the end of 2016, two more university hospitals will follow. Sequencing is done in the USA, and MKI carries out IT analysis of the results.
Nikkei Biotech news release, April 18, 2016
Mitsui Knowledge Industry (MKI) to expand cancer sequencing service „OncoPrime“